Jpmorgan Chase & CO Astrazeneca PLC Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3,983,851 shares of AZN stock, worth $311 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,983,851
Previous 3,542,410
12.46%
Holding current value
$311 Million
Previous $239 Million
13.13%
% of portfolio
0.02%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,244Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.78 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.83 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.35 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.69 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.35 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...